Results 291 to 300 of about 843,078 (353)

ROS‐Responsive Nanobubbles for Dual‐Enhanced Ultrasound and Magnetic Resonance Imaging of Tumor Oxidative Stress

open access: yesAdvanced Science, EarlyView.
We report the development of biotinylated PEGylated bilirubin‐coated perfluoropentane (bt‐PEG‐BR@PFP) nanobubbles, a novel class of ROS‐activatable and dual‐modality contrast agents that amplify both ultrasound (US) and magnetic resonance imaging (MRI) signals in response to elevated ROS.
Wonsik Jung   +6 more
wiley   +1 more source

Bacterial taxa associated with lung cancer cases in Southeast Asians: a pilot case-control study. [PDF]

open access: yesCell Oncol (Dordr)
Low A   +14 more
europepmc   +1 more source

Unraveling the nexus: Tumor mutational burden, PD-L1 expression, and oncogenic alterations in non-small cell lung cancer cytology specimens. [PDF]

open access: yesCancer Cytopathol
Dai M   +16 more
europepmc   +1 more source

A Complete Response to Immunotherapy in a Patient with Locally Advanced Squamous Cell Lung Cancer Harboring a Novel <i>TMEM178B::BRAF</i> Fusion: A Case Report. [PDF]

open access: yesDiagnostics (Basel)
Redondo-González JC   +8 more
europepmc   +1 more source

Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.

Life Science, 2021
AIMS Exosomal transfer of miRNAs affects recipient cell proliferation and chemoresistance. Here, we aimed to investigate the role of exosomal miRNAs in controlling cisplatin resistance in non-small cell lung carcinoma (NSCLC). MAIN METHODS Paired tumor
Zhiyu Song, Gang Jia, Peizhi Ma, S. Cang
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy